Infant functional status: the timing of physiologic maturation of premature infants

Susan Bakewell-Sachs1, Barbara Medoff-Cooper, Gabriel J Escobar

  • 1School of Nursing, Health, and Exercise Science, College of New Jersey, Ewing, New Jersey, USA.

Pediatrics
|May 1, 2009
PubMed

Insights

Physiologic milestones for preterm infants (born 24-32 weeks gestation) are typically met between 34-36 weeks postmenstrual age. Conditions like bronchopulmonary dysplasia impact maturation timelines, influencing discharge readiness.

Area of Science:

  • Neonatology
  • Pediatric Physiology
  • Perinatal Medicine

Background:

  • Preterm infants born between 24 and 32 weeks' gestational age experience variable physiologic maturation.
  • Understanding the timeline of achieving key milestones is crucial for managing their care and predicting discharge readiness.

Purpose of the Study:

  • To describe the maturation of physiologic milestones in preterm infants.
  • To identify factors influencing the achievement of these milestones.

Main Methods:

  • Retrospective analysis of 865 preterm infants (born ≤32 weeks gestation) from 1998-2001.
  • Data abstracted included ventilator settings, temperature, apnea/bradycardia, medications, feeding, and IV fluid requirements.
  • Multivariable quantile regression identified risk factors for achieving milestones at later postmenstrual ages.

Main Results:

  • Most infants achieved milestones between 34-36 weeks postmenstrual age, with significant inter-patient variability.
  • Feeding and oxygen milestones were generally achieved last.
  • Bronchopulmonary dysplasia and necrotizing enterocolitis significantly affected maturation timelines in younger infants.

Conclusions:

  • This study provides essential epidemiologic data on physiologic milestone achievement in preterm infants.
  • The findings aid in developing algorithms for monitoring neonatal progress and serve as a reference for future interventions.
  • Understanding these maturation timelines is critical for optimizing care and facilitating timely discharge of premature infants.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Socioemotional Development during Infancy01:30

Socioemotional Development during Infancy

Socio-emotional development in infancy is primarily shaped by early emotional responses and social connections, with temperament playing a central role. Temperament refers to the consistent patterns in an individual's emotional and behavioral responses, observable even in infancy. By examining temperament, researchers can better understand an infant's unique ways of interacting with the world, influencing subsequent personality and socio-emotional growth.
Primary Temperament Types
Stella Chess...
Piaget's Stage 1 of Cognitive Development01:14

Piaget's Stage 1 of Cognitive Development

The sensorimotor stage, the initial phase of Jean Piaget's theory of cognitive development, spans the first two years of a child's life. During this period, infants actively engage with their surroundings, building cognitive awareness through direct interaction with the world. This interaction is primarily based on sensory perception and motor actions, allowing infants to gradually understand basic physical properties and predict how objects interact within their environment.
Exploration...